1887

Microbial Genomics logo

Volume 9, Issue 5

Whole-genome sequencing and transcriptome-characterized evolution of aminoglycoside resistance in Open Access

Abstract

Antibiotic resistance of (Mtb) is a major public health concern worldwide. Therefore, it is of great significance to characterize the mutational pathways by which susceptible Mtb evolves into drug resistance. In this study, we used laboratory evolution to explore the mutational pathways of aminoglycoside resistance. The level of resistance in amikacin inducing Mtb was also associated with changes in susceptibility to other anti-tuberculosis drugs such as isoniazid, levofloxacin and capreomycin. Whole-genome sequencing (WGS) revealed that the induced resistant Mtb strains had accumulated diverse mutations. We found that A1401G was the predominant mutation in aminoglycoside-resistant clinical Mtb isolates from Guangdong. In addition, this study provided global insight into the characteristics of the transcriptome in four representative induced strains and revealed that mutated and unmutated aminoglycoside-resistant Mtb strains have different transcriptional profiles. WGS analysis and transcriptional profiling of Mtb strains during evolution revealed that Mtb strains harbouring A1401G have an evolutionary advantage over other drug-resistant strains under the pressure of aminoglycosides because of their ultra-high resistance level and low physiological impact on the strain. The results of this study should advance our understanding of aminoglycoside resistance mechanisms.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): aminoglycoside resistance , Mycobacterium tuberculosis , transcriptome sequencing and whole genome sequencing
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001022
2023-05-24
2024-04-30
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/5/mgen001022.html?itemId=/content/journal/mgen/10.1099/mgen.0.001022&mimeType=html&fmt=ahah

References

  1. WHO GLOBAL TUBERCULOSIS REPORT. Featured publication; 2021
  2. Chen Y, Wen W, Wu H, Xu L, Peng K et al. Analysis of monitoring results of tuberculosis drug-resistance in Guangdong Province from 2016 to 2020. Chinese J Antituberculosis 2022; 44:685–689
     [Google Scholar]
  3. Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC et al. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet 2020; 396:402–411 [View Article] [PubMed]
     [Google Scholar]
  4. Sabur NF, Brar MS, Wu L, Brode SK. Low-dose amikacin in the treatment of multidrug-resistant tuberculosis (MDR-TB). BMC Infect Dis 2021; 21:254 [View Article] [PubMed]
     [Google Scholar]
  5. WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2016
  6. WHO consolidated guidelines on drug-resistant tuberculosis treatment. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2019
  7. Ahmad MH, Rechenmacher A, Böck A. Interaction between aminoglycoside uptake and ribosomal resistance mutations. Antimicrob Agents Chemother 1980; 18:798–806 [View Article] [PubMed]
     [Google Scholar]
  8. Davis BD, Chen LL, Tai PC. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci 1986; 83:6164–6168 [View Article] [PubMed]
     [Google Scholar]
  9. Jian J, Yang X, Yang J, Chen L. Evaluation of the genotype mtbdrplus and mtbdrsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China. Infect Drug Resist 2018; 11:1627–1634
     [Google Scholar]
  10. Programme GT. Rapid Communication- Key changes to the treatment of drug-resistant tuberculosis WHO/CDS/TB/2019.:6. World Health Organization; 2019
  11. Brossier F, Pham A, Bernard C, Aubry A, Jarlier V et al. Molecular investigation of resistance to second-line injectable drugs in multidrug-resistant clinical isolates of Mycobacterium tuberculosis in France. Antimicrob Agents Chemother 2017; 61:e01299-16 [View Article] [PubMed]
     [Google Scholar]
  12. Vargas R, Freschi L, Spitaleri A, Tahseen S, Barilar I et al. Role of epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine resistance in Mycobacterium tuberculosis complex. Antimicrob Agents Chemother 2021; 65:e0116421 [View Article] [PubMed]
     [Google Scholar]
  13. Farhat MR, Freschi L, Calderon R, Ioerger T, Snyder M et al. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nat Commun 2019; 10:2128 [View Article] [PubMed]
     [Google Scholar]
  14. Pholwat S, Stroup S, Heysell S, Ogarkov O, Zhdanova S et al. eis promoter C14G and C15G mutations do not confer kanamycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2016; 60:7522–7523 [View Article] [PubMed]
     [Google Scholar]
  15. Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain. Ann Clin Microbiol Antimicrob 2018; 17:33 [View Article] [PubMed]
     [Google Scholar]
  16. Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand. BMC Microbiol 2014; 14:165 [View Article] [PubMed]
     [Google Scholar]
  17. Coll F, Phelan J, Hill-Cawthorne GA, Nair MB, Mallard K et al. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet 2018; 50:307–316 [View Article] [PubMed]
     [Google Scholar]
  18. Du Q, Dai G, Long Q, Yu X, Dong L et al. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagn Microbiol Infect Dis 2013; 77:138–142 [View Article] [PubMed]
     [Google Scholar]
  19. Miryala SK, Anbarasu A, Ramaiah S. Impact of bedaquiline and capreomycin on the gene expression patterns of multidrug-resistant Mycobacterium tuberculosis H37Rv strain and understanding the molecular mechanism of antibiotic resistance. J Cell Biochem 2019; 120:14499–14509 [View Article] [PubMed]
     [Google Scholar]
  20. Zhao J, Wei W, Yan H, Zhou Y, Li Z et al. Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis. Int J Med Microbiol 2019; 309:151323 [View Article] [PubMed]
     [Google Scholar]
  21. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754–1760 [View Article] [PubMed]
     [Google Scholar]
  22. Wang M, Fleming J, Li Z, Li C, Zhang H et al. An automated approach for global identification of sRNA-encoding regions in RNA-Seq data from Mycobacterium tuberculosis. Acta Biochim Biophys Sin 2016; 48:544–553 [View Article] [PubMed]
     [Google Scholar]
  23. Qin Y. Correlation between optical density and colony forming units of Mycobac-terium tuberculosis suspension; 2016; 150
  24. Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinformatics 2014; 15:293 [View Article] [PubMed]
     [Google Scholar]
  25. Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M et al. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5’ untranslated region of whiB7. Antimicrob Agents Chemother 2013; 57:1857–1865 [View Article] [PubMed]
     [Google Scholar]
  26. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A et al. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 2012; 7:e33275 [View Article] [PubMed]
     [Google Scholar]
  27. Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50:1701354 [View Article] [PubMed]
     [Google Scholar]
  28. Li Q, Gao H, Zhang Z, Tian Y, Liu T et al. Mutation and transmission profiles of second-line drug resistance in clinical isolates of drug-resistant Mycobacterium tuberculosis from Hebei Province, China. Front Microbiol 2019; 10:1838 [View Article] [PubMed]
     [Google Scholar]
  29. Engström A, Perskvist N, Werngren J, Hoffner SE, Juréen P. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2011; 66:1247–1254 [View Article] [PubMed]
     [Google Scholar]
  30. Reeves AZ, Campbell PJ, Willby MJ, Posey JE. Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2015; 59:444–449 [View Article] [PubMed]
     [Google Scholar]
  31. de Welzen L, Eldholm V, Maharaj K, Manson AL, Earl AM et al. Whole-transcriptome and -genome analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance. Antimicrob Agents Chemother 2017; 61:e01461-17 [View Article] [PubMed]
     [Google Scholar]
  32. Tang J, Liu Z, Shi Y, Zhan L, Qin C. Whole genome and transcriptome sequencing of two multi-drug resistant Mycobacterium tuberculosis strains to facilitate illustrating their virulence in vivo. Front Cell Infect Microbiol 2020; 10:219 [View Article] [PubMed]
     [Google Scholar]
  33. Truitt AR, Choi B-E, Li J, Soto AM. Effect of mutations on the binding of Kanamycin-B to RNA hairpins derived from the Mycobacterium tuberculosis ribosomal a-site. Biochemistry 2015; 54:7425–7437 [View Article] [PubMed]
     [Google Scholar]
  34. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130:797–810 [View Article] [PubMed]
     [Google Scholar]
  35. Méhi O, Bogos B, Csörgő B, Pál F, Nyerges A et al. Perturbation of iron homeostasis promotes the evolution of antibiotic resistance. Mol Biol Evol 2014; 31:2793–2804 [View Article] [PubMed]
     [Google Scholar]
  36. Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 2010; 37:311–320 [View Article] [PubMed]
     [Google Scholar]
  37. Mogre A, Veetil RT, Seshasayee ASN. Modulation of global transcriptional regulatory networks as a strategy for increasing Kanamycin resistance of the translational elongation factor-G mutants in Escherichia coli. G3 2017; 7:3955–3966 [View Article] [PubMed]
     [Google Scholar]
  38. Morris RP, Nguyen L, Gatfield J, Visconti K, Nguyen K et al. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci 2005; 102:12200–12205 [View Article] [PubMed]
     [Google Scholar]
  39. Andini N, Nash KA. Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrob Agents Chemother 2006; 50:2560–2562 [View Article] [PubMed]
     [Google Scholar]
  40. Duan W, Li X, Ge Y, Yu Z, Li P et al. Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC efflux pump regulated by WhiB7. Future Microbiol 2019; 14:47–59 [View Article] [PubMed]
     [Google Scholar]
  41. Rodriguez GM, Sharma N, Biswas A, Sharma N. The iron response of Mycobacterium tuberculosis and its implications for tuberculosis pathogenesis and novel therapeutics. Front Cell Infect Microbiol 2022; 12:876667 [View Article] [PubMed]
     [Google Scholar]
  42. Zhang L, Hendrickson RC, Meikle V, Lefkowitz EJ, Ioerger TR et al. Comprehensive analysis of iron utilization by Mycobacterium tuberculosis. PLoS Pathog 2020; 16:e1008337 [View Article] [PubMed]
     [Google Scholar]
  43. Arnold FM, Weber MS, Gonda I, Gallenito MJ, Adenau S et al. The ABC exporter IrtAB imports and reduces mycobacterial siderophores. Nature 2020; 580:413–417 [View Article] [PubMed]
     [Google Scholar]
  44. Joshi SM, Pandey AK, Capite N, Fortune SM, Rubin EJ et al. Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc Natl Acad Sci U S A 2006; 103:11760–11765 [View Article] [PubMed]
     [Google Scholar]
  45. Xu J-Y, Zhao L, Xu Y, Li B, Zhai L et al. Dynamic Characterization of Protein and Posttranslational Modification Levels in Mycobacterial Cholesterol Catabolism. mSystems 2020; 5:e00424-19 [View Article] [PubMed]
     [Google Scholar]
  46. Aguilar-Ayala DA, Tilleman L, Van Nieuwerburgh F, Deforce D, Palomino JC et al. The transcriptome of Mycobacterium tuberculosis in a lipid-rich dormancy model through RNAseq analysis. Sci Rep 2017; 7:17665 [View Article] [PubMed]
     [Google Scholar]
  47. Pawełczyk J, Brzostek A, Minias A, Płociński P, Rumijowska-Galewicz A et al. Cholesterol-dependent transcriptome remodeling reveals new insight into the contribution of cholesterol to Mycobacterium tuberculosis pathogenesis. Sci Rep 2021; 11:12396 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001022
Loading
Whole-genome sequencing and transcriptome-characterized in vitro evolution of aminoglycoside resistance in Mycobacterium tuberculosis
M Gen 9, 001022 (2023); https://doi.org/10.1099/mgen.0.001022
/content/journal/mgen/10.1099/mgen.0.001022
/content/journal/mgen/10.1099/mgen.0.001022
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL

Supplementary material 4

EXCEL

Supplementary material 5

EXCEL

Supplementary material 6

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error